AUGO vs NEM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health scores raise significant concerns, with a Piotroski F-Score of 4/9 indicating marginal financial health and no available Altman Z-Score to confirm safety from distress. Despite strong revenue growth and high operating margins, the company reports negative profit margins and ROE, alongside a dangerously high payout ratio of 780%, suggesting dividends are unsustainable. The stock trades at a steep valuation premium with a Price/Book of 17.69 and Forward P/E of 12.98, while recent earnings have consistently missed estimates—0 out of the last 4 beats and an average surprise of -86.59%. Although analyst consensus is 'strong_buy', price momentum appears disconnected from fundamentals, increasing downside risk.
NEM shows bullish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Key strengths include strong valuation and growth metrics. Price trades at a 155.7% premium to fair value estimate ($44.73), limiting near-term upside from a valuation perspective.
Compare Another Pair
Related Comparisons
AUGO vs NEM: Head-to-Head Comparison
This page compares Aura Minerals Inc. (AUGO) and Newmont Corporation (NEM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.